Alan Wilk is a seasoned biostatistician currently serving as a Senior Biostatistician at Abbott since 2023. Previously, Wilk held positions as a Senior Biostatistician at iRhythm Technologies, Inc. from 2021 to 2024, and as an Associate Manager and Biostatistician at Veradigm from 2019 to 2023. With extensive experience in clinical research, Wilk has contributed to statistical analysis plans, developed clinical data warehouses, and collaborated on FDA submissions during tenure at Heartflow, Inc., Novartis Vaccines and Diagnostics, and SRI International. Wilk holds a Bachelor of Arts in Economics from the University of California, Santa Cruz, and a Bachelor of Science in Biomedical/Medical Engineering from the University of California, Berkeley.
This person is not in the org chart
This person is not in any teams
This person is not in any offices